| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006359738 |
| P356 | DOI | 10.1038/NM.4106 |
| P932 | PMC publication ID | 4899206 |
| P698 | PubMed publication ID | 27158906 |
| P50 | author | Marco Prinz | Q30055422 |
| Steffen Jung | Q39989609 | ||
| Lukas Bunse | Q55458974 | ||
| Nathalie Pochet | Q55465156 | ||
| Alexandre Prat | Q56394627 | ||
| Niroshana Anandasabapathy | Q56881400 | ||
| Clary B Clish | Q56988961 | ||
| Lior Mayo | Q58657603 | ||
| Jack P. Antel | Q76365827 | ||
| Guillermo Izquierdo | Q87946650 | ||
| Francisco J. Quintana | Q88364866 | ||
| Chun-Cheih Chao | Q96074929 | ||
| P2093 | author name string | Hania Kébir | |
| Jorge I Alvarez | |||
| Bonny Patel | |||
| Veit Rothhammer | |||
| Ivan D Mascanfroni | |||
| Raymond Yan | |||
| Jessica E Kenison | |||
| Maisa C Takenaka | |||
| Manon Blain | |||
| Nikolaus Obholzer | |||
| P2860 | cites work | Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells | Q24293709 |
| Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks | Q24633890 | ||
| Development, maintenance and disruption of the blood-brain barrier | Q26829668 | ||
| Regulation of type I interferon responses | Q26853177 | ||
| Aryl hydrocarbon receptor control of adaptive immunity | Q26991793 | ||
| Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract | Q28238242 | ||
| An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor | Q28249782 | ||
| Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation | Q28250446 | ||
| Interferons at age 50: past, current and future impact on biomedicine | Q28259312 | ||
| Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor | Q28273769 | ||
| Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin | Q28510018 | ||
| The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis | Q29616351 | ||
| Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells | Q29618126 | ||
| Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites | Q29619788 | ||
| Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis | Q29619978 | ||
| The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins | Q29620097 | ||
| The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide | Q31144277 | ||
| The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor | Q33587787 | ||
| Aryl hydrocarbon receptor control of a disease tolerance defence pathway | Q33901562 | ||
| T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis | Q34107156 | ||
| The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. | Q34131656 | ||
| Reprogramming human endothelial cells to haematopoietic cells requires vascular induction | Q34157738 | ||
| Glial cells in the enteric nervous system contain glial fibrillary acidic protein | Q34275211 | ||
| An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis | Q34375959 | ||
| The aryl hydrocarbon receptor: multitasking in the immune system | Q34411397 | ||
| Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. | Q34632490 | ||
| Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis | Q34646876 | ||
| Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis | Q35129497 | ||
| Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression | Q35564886 | ||
| Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis. | Q35747209 | ||
| USP18 lack in microglia causes destructive interferonopathy of the mouse brain | Q35762623 | ||
| Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α. | Q35765467 | ||
| Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors | Q36058143 | ||
| Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses | Q36061629 | ||
| CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes | Q36085387 | ||
| Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis | Q36094091 | ||
| Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson's Disease-like Dementia | Q36146776 | ||
| Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells. | Q36614277 | ||
| Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function | Q36907335 | ||
| Reproducibility of metabolomic profiles among men and women in 2 large cohort studies | Q37265647 | ||
| The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice. | Q37403106 | ||
| Astrocyte barriers to neurotoxic inflammation | Q37597818 | ||
| Diversity of astrocyte functions and phenotypes in neural circuits | Q37601163 | ||
| IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. | Q37659617 | ||
| Heterogeneity of CNS myeloid cells and their roles in neurodegeneration | Q37939514 | ||
| Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology | Q38134459 | ||
| Mechanisms of white matter damage in multiple sclerosis | Q38182524 | ||
| 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells | Q38336597 | ||
| Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways | Q38550041 | ||
| Astrocyte-encoded positional cues maintain sensorimotor circuit integrity. | Q40717814 | ||
| Regional astrocyte allocation regulates CNS synaptogenesis and repair. | Q40757384 | ||
| Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers | Q42942128 | ||
| Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis | Q44897644 | ||
| Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. | Q45760347 | ||
| Astronomy: Clue to an ancient cosmic-ray event? | Q47193778 | ||
| New pieces in the puzzle: how does interferon-beta really work in multiple sclerosis? | Q47697568 | ||
| Building up the blood-brain barrier | Q48265505 | ||
| Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions. | Q48435937 | ||
| The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence | Q48797548 | ||
| Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS. | Q48802284 | ||
| Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. | Q48819558 | ||
| Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. | Q54412643 | ||
| SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice | Q56875354 | ||
| Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System | Q56984582 | ||
| Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice | Q56984592 | ||
| TLR signaling tailors innate immune responses in human microglia and astrocytes | Q57041985 | ||
| Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis | Q80819720 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nervous system | Q9404 |
| astrocyte | Q502961 | ||
| indole-3-carboxaldehyde | Q27103575 | ||
| P304 | page(s) | 586-597 | |
| P577 | publication date | 2016-05-09 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor | |
| P478 | volume | 22 |
| Q90308566 | 1H-NMR Metabolomics Analysis of the Effect of Rubusoside on Serum Metabolites of Golden Hamsters on a High-Fat Diet |
| Q58701288 | A Functionally Defined Astrocyte Population Identified by c-Fos Activation in a Mouse Model of Multiple Sclerosis Modulated by S1P Signaling: Immediate-Early Astrocytes () |
| Q60951664 | A Metabologenomic Approach Reveals Changes in the Intestinal Environment of Mice Fed on American Diet |
| Q49647134 | A gut feeling about multiple sclerosis |
| Q93077579 | A potential role for the gut microbiome in substance use disorders |
| Q56379902 | A probiotic modulates the microbiome and immunity in multiple sclerosis |
| Q38806102 | A review of the immunomodulatory role of dietary tryptophan in livestock and poultry. |
| Q97636536 | AHR is a Zika virus host factor and a candidate target for antiviral therapy |
| Q64086620 | Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis |
| Q58569508 | Acute microglia ablation induces neurodegeneration in the somatosensory system |
| Q99711510 | Affective Immunology: The Crosstalk Between Microglia and Astrocytes Plays Key Role? |
| Q57821114 | Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course |
| Q50146314 | An introduction to the microbiome and MS. |
| Q88671353 | Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans |
| Q90398835 | Aryl Hydrocarbon Receptor in Post-Mortem Hippocampus and in Serum from Young, Elder, and Alzheimer's Patients |
| Q42337560 | Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activity |
| Q90669581 | Aryl hydrocarbon receptor modulates stroke-induced astrogliosis and neurogenesis in the adult mouse brain |
| Q89649932 | Astrocytes and Microglia: In Sickness and in Health |
| Q48182504 | Astrocytes to the rescue! Glia limitans astrocytic endfeet control CNS inflammation |
| Q38966132 | Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases |
| Q92918938 | Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation |
| Q88877065 | Brain inflammatory cascade controlled by gut-derived molecules |
| Q90854447 | Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery |
| Q93092528 | Bridging intestinal immunity and gut microbiota by metabolites |
| Q50223200 | CNS inflammation and neurodegeneration |
| Q91559320 | Calorie restriction slows age-related microbiota changes in an Alzheimer's disease model in female mice |
| Q41584110 | Cell-Surface and Nuclear Receptors in the Colon as Targets for Bacterial Metabolites and Its Relevance to Colon Health |
| Q92324174 | Childhood growth and neurocognition are associated with distinct sets of metabolites |
| Q47262338 | Cografting astrocytes improves cell therapeutic outcomes in a Parkinson's disease model |
| Q36071876 | Communicating systems in the body: how microbiota and microglia cooperate. |
| Q89176398 | Communication Between the Microbiota and Mammalian Immunity |
| Q91423462 | Comparative analysis of CreER transgenic mice for the study of brain macrophages: A case study |
| Q39374093 | Control of immune-mediated pathology via the aryl hydrocarbon receptor |
| Q92955884 | Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39 |
| Q57170659 | Correlation of tryptophan metabolites with connectivity of extended central reward network in healthy subjects |
| Q52597824 | Cross-talk between monocyte invasion and astrocyte proliferation regulates scarring in brain injury. |
| Q64245250 | Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice via Alterations in Gut Microbiota |
| Q90862879 | Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome |
| Q55206187 | Detection of aryl hydrocarbon receptor agonists in human samples. |
| Q48001906 | Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis |
| Q64108334 | Dietary Modulation of Intestinal Microbiota: Future Opportunities in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis |
| Q90950078 | Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology |
| Q90305468 | Differences in Serum Amino Acid Phenotypes Among Patients with Diabetic Nephropathy, Hypertensive Nephropathy, and Chronic Nephritis |
| Q33808285 | Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS |
| Q90072371 | Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-β in Tg2576 Mice |
| Q91473836 | Early exposure to antibiotic drugs and risk for psychiatric disorders: a population-based study |
| Q58750497 | Emerging Role of Diet and Microbiota Interactions in Neuroinflammation |
| Q90640205 | Enteric Microbiota⁻Gut⁻Brain Axis from the Perspective of Nuclear Receptors |
| Q38973515 | Environmental control of autoimmune inflammation in the central nervous system |
| Q58720899 | Expression of the neuroprotective protein aryl hydrocarbon receptor nuclear translocator 2 correlates with neuronal stress and disability in models of multiple sclerosis |
| Q90272845 | Genetic targeting of astrocytes to combat neurodegenerative disease |
| Q92249432 | Genome-Wide Transcriptional Analysis Reveals Novel AhR Targets That Regulate Dendritic Cell Function during Influenza A Virus Infection |
| Q89356722 | Glia: An astrocytic axis |
| Q63493264 | Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in |
| Q47832545 | Gut Microbiota and the Neuroendocrine System |
| Q55236740 | Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives. |
| Q60959697 | Gut Microbiota, Fusobacteria, and Colorectal Cancer |
| Q89104008 | Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion |
| Q42221329 | Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. |
| Q37415195 | Gut dysbiosis impairs recovery after spinal cord injury. |
| Q92332225 | Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health |
| Q100694558 | Gut microbial molecules in behavioural and neurodegenerative conditions |
| Q92788040 | Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2 |
| Q42263596 | Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice |
| Q46255307 | Gut reactions: How the blood-brain barrier connects the microbiome and the brain. |
| Q39434933 | Gut-CNS-Axis as Possibility to Modulate Inflammatory Disease Activity-Implications for Multiple Sclerosis |
| Q106535191 | Gut-licensed IFNγ NK cells drive LAMP1TRAIL anti-inflammatory astrocytes |
| Q38780964 | HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication |
| Q90055105 | Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis |
| Q28566343 | Host-microbiome interactions: the aryl hydrocarbon receptor and the central nervous system |
| Q95840390 | Host-microbiota interactions in immune-mediated diseases |
| Q90385883 | How microbiota shape microglial phenotypes and epigenetics |
| Q58571221 | Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines |
| Q49374081 | Hypermetabolism and Nutritional Support in Sepsis |
| Q38699928 | IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment |
| Q89637718 | Immune cell regulation of glia during CNS injury and disease |
| Q90030117 | Immune cells and CNS physiology: Microglia and beyond |
| Q39065615 | Immunologic impact of the intestine in metabolic disease |
| Q91868740 | Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease |
| Q64080477 | Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis |
| Q52325276 | Impacts of microbiome metabolites on immune regulation and autoimmunity. |
| Q52311705 | Indole, a Signaling Molecule Produced by the Gut Microbiota, Negatively Impacts Emotional Behaviors in Rats. |
| Q92692991 | Indole-3-lactic acid, a metabolite of tryptophan, secreted by Bifidobacterium longum subspecies infantis is anti-inflammatory in the immature intestine |
| Q90044608 | Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats |
| Q54241747 | Integrative analysis of Multiple Sclerosis using a systems biology approach. |
| Q39090621 | Interactions between the microbiota, immune and nervous systems in health and disease. |
| Q55429416 | Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application. |
| Q55043186 | Interrelation of Diet, Gut Microbiome, and Autoantibody Production. |
| Q98735567 | Intestinal Dysbiosis and Tryptophan Metabolism in Autoimmunity |
| Q44042761 | Intestinal Lactobacillus in health and disease, a driver or just along for the ride? |
| Q50146310 | Investigation of probiotics in multiple sclerosis |
| Q39018403 | Irritable bowel syndrome: a gut microbiota-related disorder? |
| Q41205365 | Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus? |
| Q47211013 | Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake |
| Q37346761 | Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor |
| Q36182975 | Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity |
| Q89686934 | MAFG-driven astrocytes promote CNS inflammation |
| Q92882970 | Mapping insoluble indole metabolites in the gastrointestinal environment of a murine colorectal cancer model using desorption/ionisation on porous silicon imaging |
| Q47972723 | Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders |
| Q42366438 | Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner. |
| Q61448742 | Metabolic Checkpoints in Differentiation of Helper T Cells in Tissue Inflammation |
| Q55561652 | Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis. |
| Q92157568 | Metabolism at the centre of the host-microbe relationship |
| Q91622024 | Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients |
| Q64933072 | Methylindoles and Methoxyindoles are Agonists and Antagonists of Human Aryl Hydrocarbon Receptor. |
| Q36340571 | Microbial metabolites in health and disease: Navigating the unknown in search of function |
| Q58771083 | Microbial tryptophan catabolites in health and disease |
| Q39030609 | Microbiome-Modulated Metabolites at the Interface of Host Immunity |
| Q47653764 | Microbiota Signaling Pathways that Influence Neurologic Disease |
| Q38905774 | Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases |
| Q46524879 | Microbiota: A high-pressure situation for bacteria |
| Q59125588 | Microglia: Immune Regulators of Neurodevelopment |
| Q53818547 | Microglial control of astrocytes in response to microbial metabolites. |
| Q52595172 | Mitochonic acid 5 activates the MAPK-ERK-yap signaling pathways to protect mouse microglial BV-2 cells against TNFα-induced apoptosis via increased Bnip3-related mitophagy. |
| Q41453198 | Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota |
| Q46128928 | Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota. |
| Q57455273 | Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease |
| Q92765525 | Mono-methylindoles induce CYP1A genes and inhibit CYP1A1 enzyme activity in human hepatocytes and HepaRG cells |
| Q91048875 | Mononuclear phagocytes locally specify and adapt their phenotype in a multiple sclerosis model |
| Q101410000 | Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19 |
| Q60046972 | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity |
| Q93160297 | NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice |
| Q92059916 | Neuroimmune circuits in inter-organ communication |
| Q49266766 | Nutrients Mediate Intestinal Bacteria-Mucosal Immune Crosstalk |
| Q92082162 | Nutritional Modulation of Immune and Central Nervous System Homeostasis: The Role of Diet in Development of Neuroinflammation and Neurological Disease |
| Q51733135 | Of Microbes and Minds: A Narrative Review on the Second Brain Aging. |
| Q52381787 | Of genes and microbes: solving the intricacies in host genomes. |
| Q92875232 | Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer |
| Q92901096 | Ozone-induced changes in the serum metabolome: Role of the microbiome |
| Q96953340 | Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis |
| Q49723746 | Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes |
| Q90363319 | Potential Effects of Indole-3-Lactic Acid, a Metabolite of Human Bifidobacteria, on NGF-induced Neurite Outgrowth in PC12 Cells |
| Q60910632 | Prevalence, genotype and antimicrobial resistance of Clostridium difficile isolates from healthy pets in Eastern China |
| Q91713585 | Protective effects of bifidobacteria against enteropathogens |
| Q92719120 | Questions and (some) answers on reactive astrocytes |
| Q61796314 | Recent Advances on Microbiota Involvement in the Pathogenesis of Autoimmunity |
| Q52723440 | Reciprocal Interactions of Mitochondria and the Neuroimmunoendocrine System in Neurodegenerative Disorders: An Important Role for Melatonin Regulation. |
| Q48211277 | Regulating inflammation with microbial metabolites. |
| Q49874487 | Regulation of Astrocyte Functions in Multiple Sclerosis |
| Q39443984 | Regulation of inflammation by microbiota interactions with the host. |
| Q93096532 | Regulation of signaling mediated by nucleic acid sensors for innate interferon-mediated responses during viral infection |
| Q49990707 | Regulation of the Immune Response by the Aryl Hydrocarbon Receptor |
| Q39187735 | Role of AHR and HIF-1α in Glioblastoma Metabolism |
| Q64102179 | Role of Aryl Hydrocarbon Receptor (AhR) in the Regulation of Immunity and Immunopathology During Infection |
| Q90198235 | Role of diet in regulating the gut microbiota and multiple sclerosis |
| Q103826145 | SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target |
| Q47343176 | Salt-responsive gut commensal modulates TH17 axis and disease |
| Q91102272 | Shotgun metagenomics reveals both taxonomic and tryptophan pathway differences of gut microbiota in major depressive disorder patients |
| Q42234408 | Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation. |
| Q90341485 | Systematic Understanding of Bioactive Lipids in Neuro-Immune Interactions: Lessons from an Animal Model of Multiple Sclerosis |
| Q98177377 | Systems Biology Approaches to Understand the Host-Microbiome Interactions in Neurodegenerative Diseases |
| Q39110320 | T cell responses in the central nervous system |
| Q36340545 | Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery |
| Q46315665 | Targeting the gut microbiota by dietary nutrients: A new avenue for human health |
| Q48047320 | The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis |
| Q89494237 | The Aryl Hydrocarbon Receptor (AhR) in the Aging Process: Another Puzzling Role for This Highly Conserved Transcription Factor |
| Q58704111 | The Aryl Hydrocarbon Receptor and the Nervous System |
| Q58612537 | The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment |
| Q64273567 | The Astrocytic cAMP Pathway in Health and Disease |
| Q28069455 | The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke |
| Q39263759 | The Gut, Its Microbiome, and Hypertension. |
| Q57186276 | The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications |
| Q47148147 | The Immune System Bridges the Gut Microbiota with Systemic Energy Homeostasis: Focus on TLRs, Mucosal Barrier, and SCFAs. |
| Q90229288 | The Microbial Pecking Order: Utilization of Intestinal Microbiota for Poultry Health |
| Q37742909 | The Microbiota and Epigenetic Regulation of T Helper 17/Regulatory T Cells: In Search of a Balanced Immune System |
| Q52668332 | The Role of Astrocytes in Multiple Sclerosis. |
| Q58772726 | The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence |
| Q47824376 | The Role of Gut Microbiome and Associated Metabolome in the Regulation of Neuroinflammation in Multiple Sclerosis and Its Implications in Attenuating Chronic Inflammation in Other Inflammatory and Autoimmune Disorders. |
| Q52589945 | The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease. |
| Q60920837 | The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases |
| Q56529430 | The aryl hydrocarbon receptor and interferon gamma generate antiviral states via transcriptional repression |
| Q91341267 | The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease |
| Q42331645 | The case for autoimmune neurology |
| Q92213495 | The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis |
| Q39414187 | The gut microbiome and liver cancer: mechanisms and clinical translation. |
| Q89114871 | The gut microbiota metabolite indole alleviates liver inflammation in mice |
| Q88961131 | The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics |
| Q46317552 | The microbial metabolite indole-3-propionic acid improves glucose metabolism in rats, but does not affect behaviour. |
| Q52715835 | The microbiome and autoimmunity: a paradigm from the gut-liver axis. |
| Q39386100 | The multiple pathways to autoimmunity |
| Q92759825 | The path toward using microbial metabolites as therapies |
| Q92735130 | The progress of gut microbiome research related to brain disorders |
| Q39401642 | The remedy within: will the microbiome fulfill its therapeutic promise? |
| Q93047762 | The role of cofilin in age-related neuroinflammation |
| Q50134012 | The role of the gut microbiome in systemic inflammatory disease. |
| Q102059600 | The role of the gut microbiota and microbial metabolites in neuroinflammation |
| Q42677255 | Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease |
| Q90737847 | Therapeutic potential of aryl hydrocarbon receptor in autoimmunity |
| Q90028283 | Thinking Outside the Cereal Box: Noncarbohydrate Routes for Dietary Manipulation of the Gut Microbiota |
| Q50237557 | Timing the Microbes: The Circadian Rhythm of the Gut Microbiome |
| Q47253168 | Trace Derivatives of Kynurenine Potently Activate the Aryl Hydrocarbon Receptor (AHR). |
| Q92483739 | Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice |
| Q90811723 | Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors |
| Q91559758 | Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond |
| Q37602166 | Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis |
| Q37625525 | Tryptophan: A gut microbiota-derived metabolites regulating inflammation |
| Q39315038 | Type I interferon pathway in CNS homeostasis and neurological disorders. |
| Q38693735 | Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease |
| Q39381331 | Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System |
| Q92332751 | Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice |
| Q47639897 | Western lifestyle and immunopathology of multiple sclerosis |
| Q93017077 | Xenobiotic Receptors and Their Mates in Atopic Dermatitis |
| Q47220985 | miR-23b Suppresses Leukocyte Migration and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting CCL7. |
| Q60934575 | β-RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in mice |
Search more.